Could this molecule be 'checkmate' for coronaviruses like SARS-CoV-2?

Updated on: May 16,2025 0

Could this molecule be 'checkmate' for coronaviruses like SARS-CoV-2?

Updated on:May 16,2025 0

Media visibility and costs of new medicines under examination—what does the media highlight?

Updated on: September 28,2025 0

Media visibility and costs of new medicines under examination—what does the media highlight?

Updated on:September 28,2025 0

A new AI algorithm is working to get chemotherapy dosing right

Updated on: July 13,2025 0

A new AI algorithm is working to get chemotherapy dosing right

Updated on:July 13,2025 0

New immune targets identified in glioblastoma: CD44 and TNFSF14 may help guide future therapies

Updated on: July 14,2025 0

New immune targets identified in glioblastoma: CD44 and TNFSF14 may help guide future therapies

Updated on:July 14,2025 0

Sounding the alarm: Survey shows men are unaware of 'young man's disease'

Updated on: July 15,2025 0

Sounding the alarm: Survey shows men are unaware of 'young man's disease'

Updated on:July 15,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on: October 03,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on:October 03,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on: March 28,2025 0

Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue

Updated on:March 28,2025 0

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Updated on: May 20,2025 0

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

Updated on:May 20,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on: October 03,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on:October 03,2025 0

Cancer drug eliminates aggressive cancers in Phase I trial

Updated on: September 04,2025 0

Cancer drug eliminates aggressive cancers in Phase I trial

Updated on:September 04,2025 0